<DOC>
	<DOCNO>NCT00002449</DOCNO>
	<brief_summary>The purpose study see safe effective give HIV-positive patient L2-7001 ( type interleukin-2 ) plus anti-HIV therapy . Interleukin-2 ( IL-2 ) substance naturally produce body 's white blood cell play important role help body fight infection . IL-2 may able boost immune system people HIV infection .</brief_summary>
	<brief_title>Safety Effectiveness L2-7001 ( Interleukin-2 ) HIV-Positive Patients Receiving Anti-HIV Therapy</brief_title>
	<detailed_description>This study take place two phase . Phase A consists open-label dose-escalation L2-7001 four dose level . Ascending dose cohort five patient study . The safety tolerability L2-7001 assess preparation second phase study estimate MTD . Phase B involve randomization 190 patient ( ) one three dose level L2-7001 plus ART , ( b ) one two dosing level Proleukin plus ART , ( c ) ART alone . L2-7001 Proleukin give SC every 12 hour first 5 day 8-week cycle three cycle . Serum IL-2 level , soluble IL-2 receptor level , level pro-inflammatory cytokine evaluate 8 patient randomize treatment cohort Phase B . All patient complete phase protocol eligible screen enrollment maintenance use protocol allow access L2-7001 .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Aldesleukin</mesh_term>
	<mesh_term>Interleukin-2</mesh_term>
	<criteria>Inclusion Criteria Patients may eligible study : Are HIVpositive . Have viral load 10,000 copies/ml . Have CD4 count 300 500 cells/mm3 . Have stable antiHIV therapy 4 month . Patients must take least 2 drug , 1 must protease inhibitor nonnucleoside drug ( NNRTI ) . Are least 18 year old . Agree use effective barrier method birth control , condom , study . Exclusion Criteria Patients eligible study : Have AIDSdefining illness . ( Patients AIDSdefining illness cure may still eligible . ) Have alcohol drug abuse problem doctor feel would affect ability participate . Have cancer require chemotherapy . Have history autoimmune disease . Have uncontrolled diabetes certain thyroid problem . Have mental illness serious medical condition doctor feel would affect ability participate . Have receive IL2 past . Have take corticosteroid certain medication affect immune system past 4 week . Have take hydroxyurea past 4 month . Are pregnant breastfeeding .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2001</verification_date>
	<keyword>Recombinant Proteins</keyword>
	<keyword>Injections , Subcutaneous</keyword>
	<keyword>Interleukin-2</keyword>
	<keyword>Dose-Response Relationship , Drug</keyword>
	<keyword>CD4 Lymphocyte Count</keyword>
	<keyword>Anti-HIV Agents</keyword>
	<keyword>Viral Load</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>